SP-8203 (Otaplimastat)

Otaplimastat · Shin Poong Pharmaceutical Co. Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SP-8203 (Otaplimastat), covering 2025-03-07 to 2025-03-07. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of SP-8203 (Otaplimastat) in Patients With Acute Ischemic Stroke Receiving Thrombolytic Standard of Care [Phase 3]

See pricing